| Literature DB >> 29706763 |
Ashutosh S Phadte1,2, Puttur Santhoshkumar1, K Krishna Sharma1,2.
Abstract
Purpose: The G98R mutant of αA-crystallin is associated with the development of presenile cataracts. In vitro, the recombinant mutant protein exhibits altered structural and functional characteristics, along with the propensity to aggregate by itself and precipitate. Previously, we have reported that the N-terminal aspartate substituted form of the antiaggregation peptide, D71FVIFLDVKHFSPEDLTVK88 (αA-minichaperone or mini-αA) prevented aggregation of αAG98R. However, the mechanism of stabilization of αAG98R from aggregation is not fully understood. The purpose of this study was to determine whether the surface charge (zeta (ζ) potential) of αAG98R in the presence of the peptide chaperone contributed to the stabilization of mutant protein, and to identify the sites of interaction between αAG98R and the peptide chaperone.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29706763 PMCID: PMC5906106
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Comparison of the zeta potential of wild-type and mutant αAG98R-crystallins treated with mini–αA-chaperone.
| αAWT, 1 mg | 0 | 25 | −16.84±0.64 | 4 |
| αAG98R, 1 mg | 0 | 25 | −15.19±0.87 | 5 |
| Mini–αA, 200 μg | 0 | 25 | −19.64±2.16 | 3 |
| 1 mg αAG98R + 200 µg mini–αA | 0 | 25 | −28.64±1.68 | 2 |
| 1 mg αAG98R + 200µg mini–αA | 120 | 37 | −28.99±1.20 | 2 |
| 1 mg αAG98R + 200µg mini–αA | 60 | 42 | −27.36±1.63 | 2 |
| 1 mg αAWT + 200µg mini–αA | 0 | 25 | −17.29±0.59 | 2 |
| 1 mg αAWT + 200µg mini–αA | 120 | 37 | −17.15±0.81 | 2 |
| 1 mg αAWT + 200µg mini–αA | 60 | 42 | −17.83±1.39 | 2 |
Each replicate was scanned 5 times during each zeta potential measurement.
Figure 1Chaperone-like activity of αA-minichaperone and biotinyl-mini-αA-Bpa using ADH. Experimental details are included in the Methods section.
Identification of αA–mini–chaperone interaction sites in αAG98R crystallin.
| 404.804 5+ | 2018.9963 | 6 ppm | H[Bpa]SPEDLTVK | 113EFH |
| 579.043 4+ | 2312.1477 | 2 ppm | H[Bpa]SPEDLTVK | 13TL |
| 536.267 5+ | 2676.3046 | 2 ppm | H[Bpa]SPEDLTVK | |
| 609.063 4+ | 2432.252 | 3 ppm | H[Bpa]SPEDLTVK | 55TV |
. The amino acid in αAG98R involved in the crosslink is shown in bold.
Figure 2Fragmentation mass spectrum of the identified precursor ion (m/z 609.063 4+) obtained using MS/MS. The masses of the identified ions are indicated. The cross-link between the two peptides is also shown in the inset.
Figure 3Localization of αA-minichaperone–binding regions in αAG98R-crystallin. The underlined sequences in red represent regions of αAG98R that interact with the photoactive peptide chaperone from liquid chromatography–mass spectrometry (LC-MS) data, further confirmed with tandem mass spectrometry (MS/MS). The amino acids involved in crosslinking are labeled in blue. The mutant residue (r) is shown in the lowercase.